9 Addiction Recovery Statistics You Need to Know

What the numbers actually tell a parent

If you have been reading about addiction recovery for a while, you have probably hit the same wall twice: the numbers feel either terrifying or too vague to use. That is exhausting, and it makes real decisions harder, not easier.

Here is the shift that helps. Statistics are not a verdict on your adult child. They are a map of leverage points — the places where a choice you help make (level of care, trauma work, family involvement, how long the plan lasts) actually moves the odds.

The nine figures ahead come from SAMHSA national data, peer-reviewed trials, and systematic reviews. Each one names its population, because a study of women offenders is not the same as a study of publicly funded discharges, and both are different from a national household survey. You deserve that context before you act on a number.

Read this as a decision framework, not a scoreboard. By the end, you will have specific questions to bring to any program you are considering.

Only 1 in 5 people who need treatment get it

Start here, because this is the number that changes everything downstream. In 2024, among people aged 12 and older who were classified as needing substance use treatment in the past year, only 19.3% actually received any — meaning roughly 80% did not ¹. That is national data from SAMHSA’s most recent National Survey on Drug Use and Health, drawn from a household sample designed to represent the full U.S. population.

Sit with that for a moment. Four out of five people who could benefit from care do not get it. If your adult child is in treatment, or heading into it, they are already on the smaller side of that split — which is not nothing.

Here is what this figure means for the decisions in front of you. The treatment gap is the single biggest lever in the entire recovery picture, and it is the one families most often influence. Access is shaped by insurance navigation, transportation, timing of the offer, and whether someone who cares is willing to keep the door open when the first conversation stalls. Those are things you can affect. The odds inside a program matter, but they only exist if someone walks in.

A caveat worth naming: “needing treatment” in NSDUH is defined by survey criteria, not by a clinician sitting across from your child. The number captures scale, not diagnosis. Still, at a scale this large, the direction is clear — most people who could be helped are not being helped, and getting into care at all is the first meaningful win.

42.6% completion is the real baseline, not a promise

Once someone walks through the door, the next question is whether they finish. In 2023, across roughly 1.5 million discharges from publicly funded substance use treatment, 42.6% ended in completion, 25.1% were transfers to further treatment, 22.0% were dropouts, and about 10.3% fell into other or unknown categories ². Those numbers come from SAMHSA’s Treatment Episode Data Set, which captures publicly funded settings — not the entire private-pay landscape, and not any single program’s track record.

Read the transfer number carefully, because it is easy to misread. A quarter of episodes ended not in someone quitting, but in a move to another level of care — often stepping down from residential to a partial hospitalization program or intensive outpatient, or stepping up when a lower level of care was not enough. That is treatment working the way it is supposed to work, not a failure hidden in the data.

Completion rates also vary sharply by setting. In the same 2023 TEDS data, detoxification completion sits near 62.1%, while intensive outpatient hovers around 26.6% ². Longer, more flexible episodes are harder to finish than short, contained ones — which is worth remembering when a program’s completion rate seems modest at first glance.

74.3% of adults who ever had a problem consider themselves in recovery

If the last two numbers felt heavy, this one is the counterweight. In 2024, SAMHSA estimated that 31.7 million U.S. adults perceived they had ever had a problem with alcohol or drugs — and 74.3% of them said they consider themselves to be in recovery or recovered ¹. That is not a small trial. That is a national household estimate covering roughly 23.5 million people who have already made it to the other side of the sentence you are living in right now.

You are allowed to let that land. If your adult child is still in the hard part, it does not feel like three out of four. It feels like the one who is not.

A few things to hold in mind about what this number is, and what it is not. It is self-perceived recovery, not lab-verified abstinence, and “recovery” means different things to different people — some fully abstinent, some in medication-assisted maintenance, some rebuilding after a relapse last year. The question is asked of adults who at any point saw a problem in themselves, so it captures a long time horizon, not last month’s outcome.

The reason it matters for your decisions is simple. When you are staring at a 42.6% completion rate or a relapse figure, it is easy to assume the ceiling is low. It is not. Most people who ever struggled eventually describe themselves as recovered — and the leverage points in the sections ahead are how families and programs shift more people into that majority.

84% of people with SUD carry 4 or more adverse childhood experiences

This is the number that reframes almost everything else. Among adults in the general population, about 13% report exposure to four or more adverse childhood experiences — things like abuse, neglect, a parent’s substance use, or household violence. Among people with a substance use disorder, that figure is 84% ⁶. Roughly six times the rate. That comes from a peer-reviewed synthesis focused on young adults aged 18–25 with co-occurring SUD and mental health conditions, so the strongest read is for that age band — but the pattern shows up across the broader SUD literature too.

If you are the parent reading this, you may already be doing math you did not sign up for. What happened, what you knew, what you did not. Please hear this clearly: an ACE score is a description of exposure, not a verdict on parenting. Adverse childhood experiences include things far outside a family’s control — a car accident, a death, a community-level event, a sibling’s illness, bullying, a coach or teacher who caused harm. The score is a signal about what a nervous system has carried, not a scoreboard on who is to blame.

What the number actually tells you is why treatment that ignores trauma tends to underperform. If 84% of the people walking into an SUD program are carrying that kind of history, then a plan that only addresses the drinking or the using is treating the smoke and skipping the fire. The substance was doing a job — numbing, calming, sleeping, quieting a body that never got to feel safe. Take the substance away without doing the trauma work, and the pressure that drove the use is still there. That is a setup for relapse, not recovery.

For the decisions in front of you, this is the question to bring to any program: how do you assess trauma at intake, and how is that assessment built into the actual treatment plan — not as an optional workshop, but as clinical work with trained providers? A serious program can answer that in specifics. If the response is vague, or trauma sounds like a brochure line rather than a treatment track, keep asking.

Lifetime PTSD runs 26–52% among people with substance use disorders

The ACEs number tells you what happened. This one tells you what it turned into. Among people with substance use disorders, lifetime PTSD prevalence is estimated between 26% and 52%, and current PTSD rates fall between 15% and 42% ⁴. That range comes from SAMHSA’s synthesis of epidemiological studies, and the width of it is honest — different samples, different criteria, different years. The floor is still one in four. The ceiling is roughly half.

Run the numbers the other direction and the picture gets sharper. Among people with PTSD, lifetime rates of substance use disorders sit somewhere between 36% and 52% ⁴. In the National Comorbidity Survey, 88% of men and 79% of women with PTSD had at least one other behavioral health diagnosis ⁵. These conditions travel together. They are not two separate problems that happened to show up in the same person.

What that means for your adult child is straightforward, even if it is hard to hear. If they have a trauma history — combat, assault, a car accident, a childhood that never let their guard down — the odds that PTSD is part of the clinical picture are real, not theoretical. And a PTSD symptom untreated is a reason to use again tonight. Nightmares, hypervigilance, flashbacks, the body refusing to sleep — these are things substances quiet, at least at first.

Ask any program you are considering how they screen for PTSD at intake, who on staff is trained to treat it, and whether that treatment happens alongside the substance work or after. “After” is the wrong answer.

A 2025 trauma-informed residential model: 48% completion and d=0.67 reductions in substance involvement

Here is what happens when a residential program actually builds trauma work into the structure, not just the marketing copy. In a 2025 study of a trauma-informed care model delivered in a residential SUD setting, 48% of clients completed the full 6-week program, and the model was delivered as intended about 88% of the time — meaning staff stuck to the protocol nearly nine visits out of ten ¹³. Mixed-effects analyses showed a significant reduction in substance involvement with an effect size of d=0.67 at 3 months, alongside meaningful improvements in depression, anxiety, and PTSD symptoms tracked out to 12 months ¹³.

A quick translation, because effect sizes can feel abstract. A Cohen’s d of 0.67 is what researchers call a medium-to-large effect. In plain terms, it means the change is big enough that you would notice it in the room — in how someone sleeps, how they talk about cravings, whether they show up to the next session. It is not a rounding error.

Two honest caveats. The 48% completion rate is for a 6-week residential program, which is a shorter window than many 60- or 90-day models, and the study was a single-site feasibility evaluation, not a multi-center randomized trial. So treat it as strong contemporary evidence that a well-implemented trauma-informed residential model can work, not as a guarantee that every program calling itself trauma-informed delivers the same result.

The number to hold onto is 88%. Fidelity — whether the model is actually delivered the way it was designed — is often the difference between a program that produces results and one that produces brochures. When you ask a program about their approach, ask how they measure whether staff are actually doing what the model requires.

Integrated trauma treatment for women: 67% vs 38% abstinence at 6 months

This is one of the clearest before-and-after comparisons in the trauma-informed literature, and it deserves a careful read. In a randomized study of women in substance abuse treatment, 67% of those in an integrated trauma-informed program reported 30-day drug abstinence at the 6-month follow-up, compared to 38% of women in standard care. At 12 months, the gap widened: 75% versus 40% ⁸. Roughly double the abstinence rate, holding steady a year out.

Two things to name right away. First, this is a women-only sample. The study was designed around women because trauma histories, PTSD prevalence, and treatment barriers show up differently for women than for men, and the intervention was built to match. So the specific 67/38 and 75/40 numbers speak most directly to programs serving adult women. Do not stretch them onto every population. Second, the intervention was not just “we added a trauma group.” It was integrated services — trauma work and substance use work delivered together, by staff trained to hold both, in the same treatment plan.

What the pattern tells you generalizes even if the exact percentages do not. When trauma is treated alongside substance use rather than after it, abstinence rates in this trial did not just improve — they held. That durability is what parents actually care about. A number that looks good at discharge and collapses by month twelve is not recovery. A number that stays put for a year is the beginning of one.

If your adult daughter has a trauma history, this study is worth naming directly when you talk to a program. Ask whether their trauma track runs concurrently with substance use treatment or sequentially, and who is credentialed to deliver both. “Concurrently, by the same clinical team” is the answer that matches the evidence.

Family involvement cuts substance use frequency by 5.7% — about three fewer weeks per year

You have probably wondered whether showing up actually helps, or whether your involvement is just something you cling to because doing nothing feels unbearable. Here is what the research says. Family-involved treatments produced a 5.7% reduction in substance use frequency compared to individual therapy alone — roughly three fewer weeks per year of substance use — and those benefits persisted 12 to 18 months after treatment ended ¹⁸. That estimate comes from a synthesis focused on transition-age youth, so the specific percentage speaks most directly to families of adult children in their late teens and twenties.

A 5.7% reduction can sound modest until you translate it. Three fewer weeks per year is 21 days your adult child was not using, was not driving under the influence, was not risking an overdose, was not making a choice they would spend the next morning regretting. Small percentage. Big life.

The frequency number is one piece. The engagement picture is broader. Across the wider family-therapy literature, family involvement is linked to higher rates of entry into treatment, lower dropout rates, better long-term outcomes, and improvements in family functioning alongside the substance use gains ¹⁷. A 2026 systematic review of 11 randomized trials found family engagement consistently produced favorable outcomes on both substance use reduction and family functioning ¹⁶. That is a rare pattern — an intervention that moves multiple outcomes at once, with evidence stacked from separate research teams.

What “family involvement” means in these studies matters, so name it clearly when you talk to a program. It is not a monthly visitors’ day and a family weekend at the end. It is scheduled family therapy sessions, education on the clinical model, coaching on how to respond to specific situations, and — where appropriate — significant others integrated into the treatment plan itself. Ask what the family programming actually looks like week by week. If the answer is a brochure and a Sunday brunch, it is not the intervention the research is describing.

One honest caveat before you carry this forward. The long-term family therapy evidence beyond one year is still limited ¹⁷, and the 5.7% figure is a specific finding from a specific population. Do not let anyone sell you a guaranteed outcome. What you can trust is the direction: across trials, across populations, across research teams, families who show up in structured, clinical ways move the needle. Your instinct to stay engaged is not codependence dressed up as love. It is, on the evidence, part of the treatment.

Relapse rates track other chronic diseases — with a real debate attached

You have probably seen the 40 to 60% relapse figure quoted in every article on this topic. Here is the framing that actually helps. The National Institute on Drug Abuse compares relapse rates for substance use disorders to relapse rates for other chronic medical illnesses — the kind of numbers you see for hypertension, type 2 diabetes, and asthma when patients stop following their treatment plan ⁷. In that framing, relapse is not evidence that treatment failed. It is a signal that the plan needs to be reinstated or adjusted, the same way a doctor would raise a blood pressure dose that stopped holding ⁷.

That reframe matters because of what it changes at your kitchen table. If a relapse is a moral collapse, the next call is to a lawyer or a bed check. If a relapse is a chronic-disease flare, the next call is to the clinical team about what to change — dose, level of care, therapy focus, sleep, medication for a co-occurring condition. Same event, very different response. The second response is the one that gets people back into recovery faster.

Now the honest part. Some researchers and clinicians push back on the chronic-disease comparison, arguing it can flatten the social, behavioral, and environmental drivers of substance use in ways diabetes analogies do not carry ⁷. That critique has weight. Addiction is not only a brain condition — housing, relationships, employment, and trauma history all shape whether a plan holds. The chronic-disease frame is useful for expectations. It is not the whole clinical picture.

Turning nine numbers into questions you can ask a program

You do not need to memorize the nine statistics. You need three or four questions that come out of them, and the confidence to ask those questions plainly.

Here is what to bring to the next call. First, ask about access and completion: what is your completion rate for the specific level of care you are recommending, and where do people go when they transfer or step down ²? Second, ask about trauma: how do you screen at intake, and is trauma work delivered concurrently with substance use treatment by clinicians credentialed in both ^{8, 13}? Third, ask about family: what does family programming look like week by week, and how are parents and significant others integrated into the actual treatment plan ^{16, 17}? Fourth, ask about setbacks: what is your written relapse response, and how do you adjust the plan rather than end it ⁷?

A program that answers those four in specifics — with names of models, cadence of sessions, and how fidelity is measured — is operating from the same evidence base you just read. That is the alignment you are looking for. Not certainty. Alignment.